Raday Gilead sold RDHL
October 1, 2026 · Form 4 insider transaction
Raday Gilead sold 14,310,000 shares of RedHill Biopharma Ltd. at $0.00 per share, a transaction worth $1.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 5 days after the transaction.
Footnotes
The reporting person sold 1,431 American Depository Shares ("ADS"), of RedHill Biopharma Ltd. (the "Issuer"), each ADS represents 10,000 ordinary shares, which have no par value effective August 7, 2026, solely to satisfy tax withholding obligations incurred upon the vesting of an aggregate of 4,187 Restricted Share Units ("RSU") granted to him on March 26, 2025, and January 23, 2026. Such transaction was effected by the trustee appointed in accordance with the regulations set by the Israeli Tax Authority pursuant to a sell to cover policy and does not represent a discretionary trade by the reporting person.; The price reported in Table 1 Column 4 is $0.465 per ADS, which would be equivalent to $0.0000465 per ordinary share.